Page 57
Notes:
conferenceseries
.com
Volume 8
Journal of Alzheimers Disease & Parkinsonism
ISSN: 2161-0460
Euro Dementia 2018
May 24-25, 2018
May 24-25, 2018 | Vienna, Austria
11
th
International Conference on
Alzheimers Disease & Dementia
Development and progression of Alzheimer’s disease in Sprague-Dawley rats administered with
streptozotocin intrahippocampally
Gurmeet Kaur Surindar Singh
1, 2
, Mazzura Wan Chik
1
and
Nurul Aqmar Mohd Nor Hazalin
2
1
Universiti Teknologi MARA (UiTM)—Puncak Alam Campus, Malaysia
2
Universiti Teknologi MARA (UiTM)—Shah Alam Campus, Malaysia
A
lzheimer’s disease (AD) rat model can be reproduced via intrahippocampal (IH) administration of streptozotocin (STZ)
in the rat’s brain. The hippocampus holds a large amount of insulin receptors (IRs) which are very sensitive to STZ. IRs’
exposure to STZ prompted memory impairment and production of amyloid-beta plaques related to AD pathogenesis. The
present study is conducted to investigate the effects of IH-STZ administration on the progression of memory impairment and
formation of amyloid β (Aβ) at 3, 6 and 12 weeks of STZ-treatment. Sixty male Sprague-Dawley rats (350–450 g) were divided
into groups of control (no treatment), sham-operated (received PBS) and IH-STZ treated (G3w, G6w and G12w). STZ (3 mg/
kg; 5 µl) was administered bilaterally as a single injection into the dorsal hippocampus of the rats. The memory impairment
was studied a week before decapitation using Morris water maze test. The rats were sacrificed at week 3, 6 and 12 after STZ
administration and presence of Aβ plaques were studied using the immunohistochemistry. All IH-STZ rats showed significant
results in escape latency, total distance travelled and swimming speed (p<0.05) when compared to sham indicating memory
impairment. In conclusion, STZ when injected intrahippocampally, developed memory impairment as early as two weeks after
STZ treatment in the rats.
gurmeet9952@puncakalam.uitm.edu.myJ Alzheimers Dis Parkinsonism 2018, Volume 8
DOI:10.4172/2161-0460-C3-043